High efficacy of ABT-493 and ABT-530 in HCV genotype 1 infected patients who have failed direct-acting antiviral-containing regimens: The Magellan-i study

Authors
Category Primary study
JournalJournal of Hepatology
Year 2016
This article has no abstract
Epistemonikos ID: 2e9b94cf8104e4ca01a580b9fa56e54e7295b61e
First added on: Feb 07, 2025